Literature DB >> 33415725

How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions.

Katy Jl Bell1, Fiona F Stanaway1, Les M Irwig1, Andrea R Horvath2, Armando Teixeira-Pinto1,3, Clement Loy1,4.   

Abstract

Entities:  

Keywords:  COVID-19; Diagnostic tests and procedures; Evidence-based medicine; Infectious diseases; Respiratory tract infections

Year:  2021        PMID： 33415725     DOI： 10.5694/mja2.50907

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  2 in total

1.  Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing.

Authors:  Tze Ping Loh; Sarah J Lord; Katy Bell; Mary Kathryn Bohn; Chun Yee Lim; Corey Markus; Hernan Fares Taie; Khosrow Adeli; Giuseppe Lippi; Sverre Sandberg; Andrea Horvath
Journal:  Clin Biochem       Date:  2020-11-20       Impact factor: 3.281

2.  Diagnostic accuracy of thirteen COVID-19 (SARS-CoV-2) rapid antigen self-tests with very high sensitivity approved for home use in Australia.

Authors:  Edwin A Shores; Jamie Berry
Journal:  Aust N Z J Public Health       Date:  2022-08-04       Impact factor: 3.755
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.